우리나라 백신의 수출경쟁력 분석

A Study on Vaccine Export Competitiveness of Korea: Focusing on Market Share, Trade Specialization Index and Revealed Comparative Advantage

Abstract—OBJECTIVES This study aims to analyze the vaccine export competitiveness of Korea by comparing 19 countries. METHODS We used the import and export data of 20 countries including Korea, extracted from TradeMap database. Using the data, 3 trade indexes: Market Share, TSI(Trade Specialization Index), and RCA(Revealed Comparative Advantage) are calculated. The period of the analysis is 10 years, but data of 10 years are too big to handle. So, this study just focus on 3 points of the years: 2010, 2015, 2020. RESULTS Korea s vaccine market share is less than 1%, and specializing in imports rather than exports. Korea vaccine also has a comparative inferiority in vaccine exports compared to other countries. CONCLUSIONS Considering the 3 trade indexes together, vaccine export competitiveness of Korea is low. Various strategies are needed to increase the export competitiveness.